Cambium Analytica is an NSF-owned biotechnology company providing analytical testing, product development, and contract research for the natural products, dietary supplement, and botanical industries.
Cambium Analytica is a Traverse City, Michigan-based company specializing in analytical testing, product development, and contract research for the natural products industry. Founded in 2019, the firm provides scientific services to markets including natural foods, dietary supplements, botanical products, and natural pharmaceuticals. Its technical capabilities include analytical testing for identity and potency, stability and shelf-life analysis, and custom research projects. The company utilizes advanced laboratory technologies, such as ICP-MS, GC-MS, and UV-Vis, to support regulatory compliance, quality control, and label accuracy. It maintains ISO/IEC 17025 accreditation and operates specialized testing facilities, including a subsidiary focused on PFAS environmental analysis.
The company serves as a scientific partner for businesses seeking to navigate competitive natural product markets by ensuring product integrity, safety, and regulatory alignment. By offering rapid turnaround times and integrated software features for sample tracking and compliance management, Cambium Analytica supports clients from initial research and development through to market-ready product verification. Following significant growth in its operations and laboratory capabilities, the company was acquired by NSF in October 2025, further solidifying its role in the industry’s testing and quality assurance landscape.